This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Hanmi Holdings Co., Ltd., Hanmi Pharm. Co., Ltd., Slsbio Co., Ltd.. Active years: 2011-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Seongnam-si, KR (2011 - 2014)
- Gyeonggi-do, KR (2024)
Company Filing History:

Years Active: 2011-2024
Title: The Innovations of Se Young Kim: A Pioneer in Cancer Inhibition
Introduction: Se Young Kim, an innovative inventor based in Seongnam-si, South Korea, has made significant contributions to the field of pharmaceuticals, particularly in developing compounds aimed at combating cancer. With a total of three patents to his name, his latest inventions showcase a commitment to advancing medical science.
Latest Patents: Se Young Kim's latest patents include transformative inventions such as "Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereof." This invention relates to a novel quinazoline derivative compound, designed to selectively inhibit diseases caused by the overactivity of tyrosine kinases, thus offering a targeted approach to treatment. Another noteworthy patent is the "Amide derivative for inhibiting the growth of cancer cells." This invention provides a unique amide derivative and a pharmaceutical composition that serves as an active ingredient in cancer treatment.
Career Highlights: During his career, Se Young Kim has worked with prestigious companies such as Hanmi Holdings Co., Ltd. and Hanmi Pharm. Co., Ltd. These experiences have not only shaped his technical expertise but also positioned him as a key player in pharmaceutical innovation. His research focuses on the development of effective therapeutic agents, cementing his reputation in the field.
Collaborations: Throughout his career, Se Young Kim has collaborated with notable colleagues, including Maeng Sup Kim and Gwan Sun Lee. These partnerships have facilitated the exchange of ideas and driven advancements in their shared mission of addressing critical health challenges.
Conclusion: Se Young Kim stands out as a brilliant inventor whose pioneering work has the potential to impact cancer treatment significantly. His latest patents reflect a deep understanding of pharmaceutical innovation and a dedication to developing solutions that can improve patient outcomes. As Se Young Kim continues to innovate, the medical community eagerly anticipates the future fruits of his labor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile